STML
Allianz Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-52,863
| Closed | -$256K | – | 2109 |
|
|
2020
Q1 | $256K | Sell |
52,863
-720
| -1% | -$3.49K | ﹤0.01% | 1797 |
|
|
2019
Q4 | $570K | Buy |
53,583
+3,486
| +7% | +$37.1K | ﹤0.01% | 1888 |
|
|
2019
Q3 | $522K | Buy |
50,097
+28,788
| +135% | +$300K | ﹤0.01% | 1885 |
|
|
2019
Q2 | $326K | Buy |
21,309
+1,427
| +7% | +$21.8K | ﹤0.01% | 2039 |
|
|
2019
Q1 | $255K | Buy |
19,882
+108
| +0.5% | +$1.39K | ﹤0.01% | 2100 |
|
|
2018
Q4 | $188K | Buy |
+19,774
| New | +$188K | ﹤0.01% | 2065 |
|
|
2013
Q4 | – | Sell |
-25,500
| Closed | -$1.16M | – | 1914 |
|
|
2013
Q3 | $1.16M | Buy |
+25,500
| New | +$1.16M | ﹤0.01% | 1324 |
|